IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

5AM Venture Management, LLC

Q1 2025 Holdings

Filed 2025-05-15 | 31 holdings | $264.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Entrada Therapeutics Inc(TRDA)COM29384C108$39.9M4,408,37915.1%
Enliven Therapeutics Inc(ELVN)COM29337E102$26.0M1,322,4779.8%
Dianthus Therapeutics Inc(DNTH)COM252828108$18.6M1,027,7117.1%
Skye Bioscience Inc(SKYE)COM NEW83086J200$15.8M9,913,1686.0%
Pharvaris N V(PHVS)COMN69605108$12.5M797,6004.7%
Centessa Pharmaceuticals PLC(CNTA)SPONSORED ADS152309100$11.9M830,9454.5%
Camp4 Therapeutics Corp(CAMP)COM13463J101$11.7M2,927,9154.4%
Biohaven LTD(BHVN)COMG1110E107$11.5M478,9724.4%
Moonlake Immunotherapeutics(MLTX)CLASS A ORD61559X104$11.0M282,3134.2%
Viridian Therapeutics Inc(VRDN)COM92790C104$9.9M736,5953.8%
Tectonic Therapeutic Inc(TECX)COM878972108$9.1M511,6603.4%
Celldex Therapeutics Inc New(CLDX)COM NEW15117B202$9.0M497,2703.4%
Tyra Biosciences Inc(TYRA)COM90240B106$8.7M939,2983.3%
Erasca Inc(ERAS)COM29479A108$7.4M5,405,4042.8%
Artiva Biotherapeutics Inc(ARTV)COM04317A107$7.1M2,353,3042.7%
Anaptysbio Inc(ANAB)COM032724106$6.7M357,7332.5%
Praxis Precision Medicines I(PRAX)COM NEW74006W207$6.4M170,0002.4%
GH Research PLC(GHRS)ORDINARY SHARESG3855L106$6.3M572,6652.4%
Eyepoint Pharmaceuticals Inc(EYPT)COM NEW30233G209$5.7M1,050,0002.2%
Viking Therapeutics Inc(VKTX)COM92686J106$4.6M189,5931.7%
VOR Biopharma IncCOM929033108$4.6M6,361,7231.7%
Surrozen Inc(SRZN)COM NEW86889P208$3.6M310,0001.4%
Protara Therapeutics Inc(TARA)COM STK74365U107$3.4M800,0001.3%
Scpharmaceuticals Inc(SCPH)COM810648105$3.2M1,200,6471.2%
Rallybio CorpCOM75120L100$2.4M3,630,7240.9%
Adverum Biotechnologies Inc(AVU0)COM NEW00773U207$2.4M541,6660.9%
Silence Therapeutics PLC(SLN)ADS82686Q101$1.3M476,2000.5%
Alector Inc(ALEC)COM014442107$1.2M995,8410.5%
Cidara Therapeutics Inc(CDTX)COM NEW171757206$1.2M56,7250.5%
Zentalis Pharmaceuticals Inc(ZNTL)COM98943L107$779.1K490,0000.3%
Mersana Therapeutics IncCOM59045L106$449.2K1,305,0000.2%